Trading Post November 16, 2026
Adobe (ADBE) became a full position at about $246, backed by buybacks and confidence it can adapt to AI competition.
Adobe (ADBE) became a full position at about $246, backed by buybacks and confidence it can adapt to AI competition.
The roaring $LION in action!
SALP exited $SNDK and $BE and seemingly near-full ported $SHAZ, which is down 63% since the end of Q3
Travere Therapeutics' FILSPARI has two FDA approvals and is driving revenue growth, while TVTX shares have nearly tripled since August 2025.
Domino’s built PULSE, online ordering and Pizza Tracker into a delivery machine, driving 10% annual global retail sales growth after its…
Nubank and MercadoLibre update target prices as Brazil’s 9% real rates, weaker currency and tighter credit favor their cost advantages and…
Floor & Decor has logged 20 straight quarters of comp transaction declines, with Q3 quarter-to-date same-store sales down about 3.8% as…
HCI Group grew Q3 revenue 13% and net income 27%, with $2 billion of invested assets driving investment income.
TPG trades 20% below its average distributable-earnings multiple despite the fastest fee-related earnings growth among alternative…
CDW CEO Chris Leahy says AI spending is entering a second wave focused on putting technology to work in everyday consumption.
American Tower’s wireless network stayed operational during the FAA ground stop, while CoreSite lifted its 2026 data center revenue growth…
Clarivate, Take-Two and Arcos Dorados lead a seven-stock Value Line screen focused on debt paydown, GTA VI economics and Latin American…
JFrog CFO Ed Grabscheid says soaring AI usage is converting into larger customer deals after an upbeat earnings report.
ZTS · long Zoetis, the animal prescription-medicines company, is presented as a long investment despite concerns around its 2026 and 2027 outlook.
Four Corners’ insider-backed asset sale cut shareholder proceeds to roughly 80% of its prior share price. A 2016 Wilh.
Alnylam’s 2022 50% phase-three gain faces FDA advisory-panel scrutiny over its amyloidosis drug’s label extension.
Campari’s five-year loyalty plan grants five votes per share, letting its controlling shareholder sell stock while retaining control and…
Talen’s post-bankruptcy nuclear assets, FREIT’s $22 Kushner bid and Calithera’s failed liquidation vote illustrate unusual small-cap…
Nuveen municipal-bond closed-end funds could unlock illiquid Energy Harbor holdings through Vistra’s acquisition, receiving cash and a…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.